ctrl K

Watchlist Price Alert

Aardvark Therapeutics Inc... (AARD)

NASDAQ: AARD · Real-Time Price · USD

10.49

-0.36 (-3.32%)

At close: Jun 17, 2025, 1:50 PM

Aardvark Therapeutics Common Stock Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q4 2023
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Dec 31, 2023
Cash & Equivalents	26.5M	61.64M	82.28M	86.17M	9.73M
Short-Term Investments	124.76M	12.02M	83K	174K	254K
Long-Term Investments	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	1.84M	2.63M	232K	108K	13K
Receivables	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a
Other Current Assets	3.29M	160K	136K	197K	127K
Total Current Assets	154.55M	74.14M	82.67M	86.99M	10.37M
Property-Plant & Equipment	628K	735K	841K	105K	155K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	2.47M	3.37M	1.07M	213K	168K
Total Assets	157.03M	77.51M	83.74M	87.2M	10.54M
Account Payables	2.56M	2.3M	666K	1.22M	1.03M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	390K	n/a	n/a	n/a	n/a
Other Current Liabilities	3.03M	896K	620K	933K	45K
Total Current Liabilities	5.98M	4.93M	2.61M	2.66M	1.38M
Long-Term Debt	336K	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	24K	126.78M	126.76M	126.84M	43.91M
Total Long-Term Liabilities	360K	127.22M	127.3M	126.84M	43.96M
Total Liabilities	6.34M	132.15M	129.91M	129.51M	45.34M
Total Debt	726K	779K	868K	108K	162K
Common Stock	n/a	n/a	n/a	n/a	n/a
Retained Earnings	-67.64M	-58.33M	-49.55M	-45.37M	-37.74M
Comprehensive Income	44K	n/a	n/a	n/a	n/a
Shareholders Equity	150.69M	-54.64M	-46.17M	-42.31M	-34.8M
Total Investments	n/a	12.02M	83K	174K	254K